ArticleGenetics2026
IPMK-1 (inositol phosphate multikinase) is required for integrin adhesion complex organization and muscle cell adhesion in Caenorhabditis elegans.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Integrin adhesion complexes (IACs) are a network of proteins that anchor cells to the extracellular matrix. In Caenorhabditis elegans muscle IACs exist at the bases of dense bodies and M-lines, and at the boundaries of adjacent muscle cells (MCBs). Proper assembly of IACs requires the RacGEF PIX-1 and members of the PIX-1 pathway. We report that investigation into the original Million Mutation Project strain that led us to uncover the role of PIX-1 in muscle, revealed a genetic enhancer of the pix-1 phenotype. Genetic mapping shows that the enhancer is a recessive mutation in ipmk-1. ipmk-1 encodes inositol phosphate multikinase and converts PIP2 to PIP3, IP3 to IP4, and IP4 to IP5. pix-1 loss of function mutants show reduced accumulation of IAC proteins at the MCB, and ipmk-1; pix-1 doubles additionally display large gaps between muscle cells. ipmk-1 similarly enhances other members of the PIX pathway including PAK-1, and the RacGAP RRC-1. Lack of ipmk-1 itself shows abnormal clumping of IAC proteins at MCBs and decreased animal locomotion. Muscle activity contributes to formation of the gap, since suppression occurs by paralysis induced by unc-13. The MCB defect of ipmk-1 is not due to decreased IP3 and Ca2+ signaling from analysis of ipmk-1; ipp-5 doubles and GCaMP Ca2+ measurements. PIP3 localizes to the MCB and between dense bodies and is decreased in ipmk-1. Mutants in DAF-18 (PTEN), which converts PIP3 to PIP2, partially suppress the clumping phenotype of ipmk-1, suggesting that the PIP3 to PIP2 ratio is important for IAC organization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.